tci Medicare Compliance & Reimbursement - 2016 Issue 7
Part D: Are You Part of the 'Opioid Epidemic?' Get Ready for Big Changes
Subscribe or sign in to view the full article.
Article Overview
This article explains how CMS proposals and related rulemaking could change Medicare Part D operations in response to concerns about opioid overutilization. It is aimed at healthcare compliance, pharmacy, and coding/reimbursement readers who need to track payer policy changes, plan design expectations, and related federal guidance. The discussion includes CMS communications, stakeholder concerns, point-of-sale edit concepts, prescription monitoring references, and access-to-treatment considerations, without providing procedural coding guidance.
Why This Topic Matters
Medicare Part D policy changes can affect prescribing, dispensing, utilization management, and beneficiary access to medications. Understanding the direction of CMS guidance helps organizations prepare for payer edits, compliance issues, and operational changes tied to opioid management.
Article Sections
-
CMS proposal overview
Introduces the CMS updates under discussion and the broad policy area they address. Summarizes the article’s focus on Medicare Part D and related opioid management concerns.
-
Point-of-sale edits and plan design expectations
Discusses proposed plan-level controls and the broader expectations CMS is signaling for Medicare Part D sponsors. Also notes the article’s mention of access considerations for beneficiaries receiving treatment.
-
Background and stakeholder reaction
Reviews the earlier round of CMS guidance and the pushback it received from stakeholders. Places the current proposal in the context of prior draft call letter discussions.
-
Interactive mapping tool and data use
Describes CMS’s online tool and its purpose in highlighting opioid-related prescribing patterns. Covers the article’s discussion of claims data and awareness efforts.
-
Alternative approaches and proposed rule concerns
Summarizes other stakeholder ideas discussed in the article and the separate proposed rule mentioned by the author. Includes the related concerns about prescription monitoring and discharge-planning requirements.
-
Timeline and resources
Provides the article’s closing notes on the public comment period, expected finalization date, and reference resources. Serves as the wrap-up for readers tracking the policy process.
What You Will Learn
- How CMS is approaching opioid-related utilization management in Medicare Part D
- What kinds of policy and operational changes are being discussed for plan sponsors
- Why stakeholders are concerned about access, workflow, and monitoring issues
- How related federal proposals and tools fit into the broader opioid policy landscape
- What timelines and public resources are mentioned for follow-up monitoring
Who Should Read This
- Medicare Part D plan sponsors
- Healthcare compliance professionals
- Pharmacy leaders
- Revenue cycle and reimbursement professionals
- Health policy readers
- Medical practice administrators
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com